GTXI GTx Inc.

1.14
-0.01  -1%
Previous Close 1.15
Open 1.13
Price To Book 1.05
Market Cap 27419102
Shares 24,051,844
Volume 118,714
Short Ratio
Av. Daily Volume 1,065,310

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued November 2, 2009.
Toremifene
Reduce fractures in men with prostate cancer
Noted August 14, 2017 that trial will not continue due to insufficient clinical benefit response (CBR).
Enobosarm
Breast cancer - advanced AR+ TNBC
Phase 2 data released September 21, 2018 did not meet primary endpoint.
Enobosarm
Postmenopausal women with stress urinary incontinence (SUI)
Phase 2 updated open-label data presented May 18, 2018 at American Urological Association (AUA) Meeting.
Enobosarm - open label
Stress urinary incontinence (SUI)

Latest News

  1. GTx (GTXI) Merger Class Action Lawsuit: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against GTx, Inc. Concerning its Proposed Merger With Oncternal Therapeutics, Inc. – GTXI
  2. INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition
  3. Lifshitz & Miller LLP Announces Investigation of Amarin Corporation plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., and The Kraft Heinz Company
  4. Editorial: GTx's fall is not a failure
  5. Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Clementia, Multi-Color, and GTx on Behalf of Stockholders and Encourages Investors to Contact the Firm
  6. GTx's legacy: The once-promising pillar of Memphis' 'biotech core'
  7. GTX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of GTx, Inc. - GTXI
  8. GTX, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger
  9. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of GTx, Inc. to Oncternal Therapeutics, Inc. is Fair to Shareholders
  10. Watch These Four Healthcare Stocks Set The Standard on Thursday
  11. GTx merges with biotech firm, new HQ to be based in San Diego
  12. GTx and Oncternal Therapeutics Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies
  13. CEOs of ServiceMaster, First Horizon, AutoZone react to FedEx Logistics move
  14. Analysis: Positioning to Benefit within Skyworks Solutions, Atmos Energy, Ellie Mae, ScanSource, REV Group, and GTx — Research Highlights Growth, Revenue, and Consolidated Results
  15. Recent Analysis Shows Automatic Data Processing, GTx, Ionis Pharmaceuticals, TriNet Group, Ternium S.A, and UNIVERSAL INSURANCE HOLDINGS INC Market Influences — Renewed Outlook, Key Drivers of Growth
  16. Zacks.com featured highlights include: Guess?, GTX, NCI, EMCOR and Mitek
  17. What Overvaluation? 5 Stocks With Rising P/E Are Good Buys
  18. GTx: 3Q Earnings Snapshot
  19. GTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update